Tag: Finds

Categories
Health

Single dose cuts an infection charge by 65%, examine finds

Single dose cuts infection rate by 65%, study finds

James Shaw, 82, receives Oxford University / AstraZeneca COVID-19 vaccine from advanced nurse Justine Williams on January 4, 2021 at Lochee Health Center in Dundee, Scotland, UK.

Andy Buchanan | Reuters

LONDON – A single dose of the Covid-19 vaccine from Oxford-AstraZeneca or Pfizer-BioNTech drastically reduces the risk of infection in adults of all ages, British researchers have found.

Two studies published on Friday analyzed more than 1.6 million nasal and throat swabs from 373,402 people between December and April. The data was collected as part of the ongoing Covid-19 infection survey carried out by Oxford University, the UK Office for National Statistics and the UK Department of Health and Welfare.

The researchers found that 21 days after a single dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccine, new Covid infections – both symptomatic and asymptomatic – had decreased by 65%.

Symptomatic infections decreased by 74% three weeks after a single dose of either vaccine, while asymptomatic cases decreased by 57%, the data showed.

A second dose of vaccine reduced the overall infection rate by 70%, reducing symptomatic Covid infections by 90% and asymptomatic cases of the virus by 49%.

The researchers compared these effects to the natural immunity obtained from infection with the virus.

However, they warned that the fact that vaccinated people could still be infected – even if those infections were mostly asymptomatic – meant “transmission possible”.

The study found that vaccines had a similar effect in reducing infection rates in adults of all ages. Their ability to reduce infection was also similar, regardless of whether the participants had long-term health conditions or not.

What about antibody resistance?

The scientists also looked at the effects of Covid vaccinations on participants’ antibody levels.

They found that older adults – especially those over 60 – who had never been infected with Covid had a lower immune response to a single dose of vaccine than those who had previously been infected with the virus.

Antibody responses to two doses of the Pfizer BioNTech vaccine were high in all age groups. The data showed that older adults were able to achieve antibody levels similar to those who received a vaccine dose after a previous Covid infection.

Too few people in the UK had received two doses of the Oxford AstraZeneca vaccine for researchers to assess the effects on antibody response. However, it was found that immune responses to a first dose differed between the Oxford AstraZeneca vaccine and the Pfizer BioNTech vaccine.

Antibody levels rose more slowly after a single dose of the Oxford-AstraZeneca vaccine than after the Pfizer-BioNTech alternative. However, after a dose of the latter, antibody levels fell more rapidly, especially in older adults, so patients achieved antibody levels similar to those seen after an initial dose of the Oxford-AstraZeneca vaccine.

Although immune responses differed between age groups, the scientists emphasized that there was no group that did not respond to either vaccine. However, a small number of people – less than 5% – had poor immune responses to both vaccines.

Important to get the second dose

The Oxford-AstraZeneca vaccine has been approved for use in the UK, India and several other countries, but has been temporarily suspended in some markets amid concerns that it could be linked to rare blood clots. Global health officials have stated that the benefits of giving the vaccine continue to outweigh the risks.

The WHO recommends an interval of eight to 12 weeks between the first and second dose of the Oxford AstraZeneca vaccine.

The Pfizer BioNTech vaccine is also given in several countries, including the United States. The U.S. Centers for Disease Control and Prevention recommends receiving a second dose of the vaccine three weeks after the first.

In February, the UK started a study to see if mixing doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could be effective.

Sarah Walker, professor of medical statistics and epidemiology at Oxford University and chief investigator and academic director of the Covid-19 infection survey, said Friday that scientists are still not sure how strong and how long an antibody response is. was needed for long-term protection against Covid.

David Eyre, associate professor at Oxford University’s Big Data Institute, added that the results released on Friday highlighted the importance of a second dose of vaccine for increased protection.

Categories
Health

Research Finds Many With Delicate Covid Have New Illnesses Months Later

Study Finds Many With Mild Covid Have New Ailments Months Later

Most adults who test positive for the coronavirus do not need to be hospitalized, but usually seek medical help in the months that follow. Two-thirds of those who do this develop a state of health that they did not have before.

These are the findings of a study conducted by researchers from the Centers for Disease Control and Prevention and Kaiser Permanente, which included approximately 3,171 members of the Kaiser Permanente Georgia Integrated Health System. More than half were black.

The message for patients is that even with mild Covid-19, “months after initial diagnosis, new or persistent symptoms may appear,” said Dr. Alfonso C. Hernandez-Romieu, Infectious Disease Specialist at the CDC and the lead author of the study. “And it’s important that people make sure they see their doctors,” he said to express their concerns.

“It is equally important,” he added, “that clinicians recognize that there can be these long-term effects and really make sure that they validate patients, treat them with empathy, and try to do their best to help them.”

Doctors need to monitor patients for Covid-19-related complications that can be very serious, such as blood clots, he said.

The study did not compare patients who tested positive for the coronavirus with patients who did not. As a result, the authors couldn’t tell whether people who recovered from mild Covid-19 cases made more doctor visits than those who never had the virus.

However, two-thirds of patients with mild illness sought medical help one to six months after their Covid-19 diagnosis, and about two-thirds of patients seeking treatment were diagnosed with an entirely new condition. The new diagnoses included cough, shortness of breath, heart rate disturbances, chest or throat pain, and fatigue, “which are likely to be persistent Covid-19 symptoms,” the study said.

Those who received more medical attention included adults ages 50 and older, women, and those with underlying health conditions. Black adults were also slightly more likely to seek care than others. Overall, however, the authors found that the number of visits decreased over time.

The potential for long-term complications, even after a mild course of the disease, underscores the need for preventive measures and vaccinations, said Dr. Hernandez-Romieu.

“There’s a lot we don’t know about post-Covid conditions,” he said. “Even if the majority of people don’t have severe Covid or end up in hospital, the potential for long-term health effects is really important.”

Categories
Health

FDA finds poor situations at Baltimore plant that ruined J&J doses

FDA finds poor conditions at Baltimore plant that ruined J&J doses

A detail of Janssen Johnson & Johnson’s COVID-19 vaccine that is not currently being issued because it has been on hold.

Allen J. Cockroaches | Los Angeles Times | Getty Images

The Food and Drug Administration said Wednesday a facility in Baltimore that ruined millions of Johnson & Johnson Covid-19 vaccine doses was unsanitary and unsuitable for making the shots.

The FDA asked Emergent BioSolutions, which operates the facility, to temporarily suspend production of materials for Covid-19 vaccines earlier this month as the U.S. agency initiated an inspection.

“The company has not adequately trained personnel involved in manufacturing operations, quality control sampling, weighing and dispensing, and engineering operations to prevent drug cross-contamination,” FDA investigators wrote in the report.

The eight-day inspection earlier this month revealed a number of alarming quality issues throughout the facility.

In a 13-page report, the inspectors wrote that the facility used to manufacture the vaccine “was not kept in a clean and sanitary condition” and “was not of the appropriate size, design and location for cleaning, maintenance and to facilitate proper operation. “”

FDA inspectors said paint was peeling in multiple places and walls were damaged, which could affect the facility’s “ability to adequately clean and disinfect.” They also found that when handling waste or materials used to make vaccines, employees did not follow standard operating procedures to ensure they were not contaminated.

The facility has not been approved by the FDA to manufacture or distribute Johnson & Johnson’s Covid-19 vaccine, and none of the doses manufactured at this facility have been marketed for use in the United States.

In a statement, J&J said it had “stepped up its oversight of drug manufacturing at the Emergent BioSolutions Bayview facility, including additional controls and personnel, to ensure that the quality standards of our company and the US Food & Drug Administration ( FDA) are complied with. “”

“Johnson & Johnson will exercise its regulatory authority to ensure that all FDA observations are promptly and fully considered,” it said.

Robert Califf, former FDA commissioner under the Obama administration, said that while the problems at the Baltimore plant appear “troubling”, manufacturing issues are emerging and one reason FDA oversight is so important.

“Supply chain and manufacturing are really complicated issues, but that’s why you need an FDA and inspections, and it’s the shared responsibility of the FDA and the companies themselves,” he told CNBC in a telephone interview.

Earlier this month, the Biden administration hired J&J to run the Baltimore facility after US officials learned that Emergent, a contract manufacturer that made vaccines for J&J and AstraZeneca, mixed the ingredients for the two shots would have. Officials also stopped production of the AstraZeneca vaccine.

The interruption in production of new materials is the most recent setback for J & J. Last week, the FDA and Centers for Disease Control and Prevention advised states to temporarily discontinue use of J & J’s vaccine “out of caution” after six Women had developed a rare but potentially life-threatening bleeding disorder in which one person was dead and one was in critical condition. A key CDC panel is due to meet on Friday to make a recommendation on how to use the vaccine.

The FDA said Wednesday that its actions at the Baltimore facility had nothing to do with the ongoing evaluation of the coagulation cases.

This is a developing story. Please try again.

Categories
Entertainment

Bradley Whitford Finds Inspiration within the Theater (and Canine Park)

4th Dog parks Everyone who knows me knows that I am completely obsessed with dogs. Which is pathetic when I was filming in Toronto and couldn’t bring the dogs, I went to the dog park. This very cute Canadian woman I saw there every day came to me and said: “Which one is yours?” And I said, “Oh, I don’t have any. I just miss my dog. I’m not at home. “And she stepped away from me like I was an elementary school pederast.

There are roles that I have played that are combinations of dogs in a dog park. When I had to play Hubert Humphrey [in HBO’s “All the Way”]I realized he was a cross between a corgi and a boxer. I’m just finding a fascinating portrayal of characters in a dog park. It’s like going into a four-legged mask class.

5. “Aretha’s Gold” My father’s mother was legally blind. She had a record player that came from the library for the blind and I would borrow it. Before every high school performance, I put on Aretha’s Gold and locked myself in my room or basement and turned it all the way up and jumped around and sang. And that became a kind of warm-up exercise. So if I’m nervous to this day, I’ll blow “Aretha’s Gold”.

6th ’92 Theater at Wesleyan University When I was with Wesleyan it was where all the student initiated productions were held and this is where I fell in love with acting. It was this joyful place that had been a church. I just got “Tick, Tick … Boom!” with Lin-Manuel Miranda, who felt the same way. There he began to write “In the Heights”. It’s just this magical place. When I first saw “Hamilton” I had no idea what kind of emotional reaction I was going to have and I remember crying after the show. And I said to Lin, “You are making the theater a church.” There’s something about the ’92 theater and the freedom of this place – and how bold you could be before trying this professionally – that nourishes creatively.

7th Yo-Yo Ma Its relationship to the Bach prelude [of Cello Suite No. 1 in G major] is amazing to me. People always say of “The West Wing”: “Are there moments that stand out?” And for many of us, it was the day that Yo-Yo Ma came and played that piece, and he was the most generous, unpretentious person. He came into a room full of probably a hundred background artists with his extraordinary cello and said, “Anyone want to play this? Does anyone want to hold it? “His aim is to break through the boundaries of hierarchy and demands in his classical music world.

That day he was playing that piece and I was supposed to have this emotional breakdown. You shoot him first and you have a shot of it, and then at some point you turn around and come to me. Technically, it doesn’t even have to be there, let alone play. And take after take after take, he plays it with all his heart. It was just amazing.

Categories
Health

Sleeping Too Little in Center-Age Might Increase Dementia Threat, Examine Finds

Sleeping Too Little in Middle-Age May Raise Dementia Risk, Study Finds

The correlation was also whether or not people were taking sleeping pills and whether or not they had a mutation called ApoE4, which increases the likelihood of people developing Alzheimer’s disease, said Dr. Sabia.

The researchers did not find a general difference between men and women.

“The study found a modest, but I would say, somewhat important link between short sleep and risk of dementia,” said Pamela Lutsey, an adjunct professor of epidemiology and community health at the University of Minnesota who was not involved in the research. “Short sleep is very common and can therefore be important on a societal level, even if it is only marginally linked to the risk of dementia. Short sleep is something that we are in control of and that you can change. “

As with other research in the field, however, the study had limitations that prevent it from being proven that inadequate sleep can lead to dementia. Most of the sleep data was self-reported, a subjective measurement that isn’t always accurate, experts said.

At one point, nearly 4,000 participants had sleep duration measured with accelerometers, and that data was consistent with their self-reported sleep times, the researchers said. However, this quantitative measurement came late in the study, when participants were around 69 years old, which made it less useful than if it had been obtained at a younger age.

In addition, most of the participants were white and better educated and healthier than the entire UK population. And when researchers rely on electronic health records to diagnose dementia, they may have missed some cases. They also couldn’t identify the exact types of dementia.

“It is always difficult to know what to draw from such studies,” wrote Robert Howard, professor of geriatric psychiatry at University College London, one of several experts who gave Nature Communications comments on the study. “Insomnia – which probably doesn’t need anything else to think about in bed,” he added, “shouldn’t worry about heading for dementia unless you fall asleep right away.”

There are compelling scientific theories about why not getting enough sleep could worsen your risk of dementia, especially Alzheimer’s. Studies have shown that cerebrospinal fluid amyloid, a protein that clumps up in plaques in Alzheimer’s disease, “increases when you are sleep deprived,” said Dr. Music. Other studies on amyloid and another Alzheimer’s protein, tau, suggest that “sleep is important in removing proteins from the brain or limiting production,” he said.

Categories
Health

Finland Is Once more the World’s Happiest Nation, Report Finds

Finland Is Again the World's Happiest Country, Report Finds

In Finland, a relatively egalitarian society, people tend not to be fixated on “keeping up with the Joneses”.

“People are often pretty good at social standards,” said Antti Kauppinen, professor of philosophy at the University of Helsinki. “That is based on the training; Everyone has access to a good education. Income and wealth differences are relatively small. “

David Pfister, an Austrian architect who lives in Oulunkyla, a suburb of Helsinki, said he would describe Finns as happy, but it was hard to tell if they were happy. “The baby has increased our happiness,” said his wife, Veera Yliniemi, a teacher. Another man in the same suburb, Janne Berliini, 49, said he was lucky enough. “I have work,” he said. “The basic things are fine.”

People in Finland also tend to have realistic expectations of their lives. But when something in life exceeds expectations, people will often act humbly, preferring a self-deprecating joke to boasting, said Sari Poyhonen, professor of linguistics at Jyvaskyla University. Finns, she said, are professionals at keeping their luck a secret.

This year’s report received little coverage in the Finnish news media. “Finland is still the happiest country in the world,” began a short article that appeared in the daily Ilta-Sanomat.

All of the top 10 countries – including the four other Nordic countries – have different political philosophies than the United States, # 14 on the list, behind Ireland and ahead of Canada. Lower levels of happiness in the United States could be caused by social conflict, drug addiction, lack of access to health care, and income inequality, said Dr. Wang.

Things are far from perfect in Finland. As in other parts of the continent, right-wing nationalism is on the rise, and unemployment at 8.1 percent is higher than the average unemployment rate of 7.5 percent in the European Union.

Categories
World News

U.Okay. says under-30s ought to get a non-AstraZeneca possibility; E.U. finds a ‘potential hyperlink’ to uncommon clots.

U.K. says under-30s should get a non-AstraZeneca option; E.U. finds a ‘possible link’ to rare clots.

The UK said Wednesday that it would offer alternatives to the AstraZeneca vaccine for adults under 30 as European regulators identified a “possible link” with rare blood clots, a setback for the world’s most widely used vaccine and a blow for the 100+ Described countries relying on it to save lives amid a global surge in coronavirus cases.

The European regulator, the European Medicines Agency, has no longer advised restricting the use of the vaccine in the 27 countries of the European Union, stating that it is up to national authorities to decide who should receive which vaccine.

Until the announcement, the UK had never let up in the use of the vaccine, making it a holdover in Europe, although many countries discovered unusual, sometimes fatal, blood clots in some recipients. However, there is evidence that very few Britons were also affected, forcing the country to reduce the use of a vaccine, which is the backbone of its world’s best immunization program, among younger people.

Concerns about the blood clots have threatened the pace of vaccination well beyond Europe. At least 111 countries of different incomes have administered doses of AstraZeneca’s shot, making it the most powerful weapon of international aid groups in the fight against the death toll in AstraZeneca Countries with a shortage of vaccines.

Both UK and European regulators said it was possible the clots were linked to the vaccine but that more research was needed. The European regulators described the cases as a serious but “very rare” side effect.

According to official information, the European regulatory authorities had received reports of 222 cases of the rare blood clotting problem in Great Britain and the European Economic Area with 30 countries (European Union plus Iceland, Norway and Liechtenstein) by Sunday. They said that about 34 million people in those countries had received the AstraZeneca vaccine and that the coagulation problems occurred at a rate of about 1 in 100,000 recipients. The condition can be treated.

European regulators said they had carried out detailed reviews of 86 cases by March 22, of which 18 were fatal.

The agency reiterated that the general benefits of the vaccine still outweighed the risks, but urged health professionals and recipients of the shot to be careful about symptoms such as shortness of breath, chest pain, or leg swelling.

Many European countries have restricted the use of the vaccine in younger people as some scientists believe they are at greater risk of developing the rare blood clots. You also have a lower risk of developing severe Covid-19, which raises the safety bar for any vaccine given to younger people.

However, the regulator said it had not concluded that age or gender posed a specific risk and would investigate the issue further.

“This case clearly shows one of the challenges posed by large-scale vaccination campaigns,” said Emer Cooke, head of the agency, in a press conference Wednesday. “When millions of people receive these vaccines, very rare events that were not identified during clinical trials can occur.”

“The risk of mortality from Covid is much greater than the risk of mortality from the side effects,” added Ms. Cooke.

No other vaccine has sparked as much controversy as the shot by the British-Swedish company who used the Block Spats on supply cuts, its effectiveness and ultimately on rare but sometimes fatal blood clots that have been reported in some recipients.

These concerns prompted several European countries to first restrict the use of AstraZeneca in older age groups and then suspend it on reports of blood clots, only to reintroduce it last month after the European Medicines Agency issued a preliminary opinion on the vaccine’s benefits outweighing the risks .

Because doctors reported a higher incidence of severe blood clots in younger people, some countries decided to stop giving the shot to anyone under the age of 55.

Europe’s concerns about the vaccine’s side effects are also likely to threaten global vaccination efforts, with much of the developing world relying on the AstraZeneca vaccine to help fight the pandemic. The shot is the cornerstone of Covax, a program designed to make vaccine access more equitable around the world.

The vaccine appeared to trigger an immune response in which antibodies bind to platelets and activate them, German doctors and the European Medicines Agency have said. These platelets, in turn, caused dangerous clots to form in certain parts of the body, including veins that drain blood from the brain, leading in some cases to a rare type of stroke.

Doctors have said why the antibodies develop in these people is not known. Some component of the vaccine or an excessive immune response – or both – could be the cause, they said.

There is no known disease that makes patients more susceptible to this coagulation disorder after vaccination, according to the European regulatory authorities.

Categories
Business

EU medicines regulator finds doable hyperlink between AstraZeneca Covid vaccine and blood clots

EU medicines regulator finds possible link between AstraZeneca Covid vaccine and blood clots

Syringes are filled with Astrazeneca’s vaccine in the pharmacy.

Christopher Neundorf | Image Alliance | Getty Images

LONDON – Europe’s Medicines Agency announced on Wednesday a possible link between the coronavirus vaccine developed by AstraZeneca and Oxford University and rare blood clotting problems in adults who received the shot.

It comes after a review of all currently available evidence in extremely rare cases of unusual blood clots in some vaccinated individuals.

Emer Cooke, executive director of the European Medicines Agency, said in a televised press conference that the regulator’s safety committee “has confirmed that the overall benefits of the AstraZeneca vaccine in preventing Covid-19 outweigh the risks of side effects.”

“A plausible explanation for these rare side events is an immune response to the vaccine that is similar to that seen in heparin-treated patients,” said Cooke, noting that it was heparin-induced thrombocytopenia.

The EMA has commissioned further research to investigate the link between the vaccine and blood clots, and said its safety committee had concluded that unusual blood clots with low platelets should be listed as “very rare” side effects of the shot. It also drew the public’s attention to other possible side effects that are flagged as adverse drug reactions on the product information of the vaccine.

The European Medicines Agency said it was “of great importance” that health professionals and those receiving the Oxford-AstraZeneca vaccine are aware of these risks and look out for possible symptoms, typically in the first two weeks after vaccination occur.

“These include, for example, shortness of breath, chest pain, swelling in the leg, persistent abdominal pain, neurological symptoms such as severe or persistent headaches or blurred vision and skin bruises beyond the injection site,” said Dr. Sabine Straus, chair of EMA’s security committee, said at the same press conference.

AstraZeneca’s shares fell nearly 1% during afternoon trading in London.

The Oxford-AstraZeneca shot has been followed by safety concerns in recent weeks, and several European countries temporarily stopped using the vaccine last month.

The EMA said on March 31 that it had found the shot to be safe and effective, but added that it could not rule out the possibility of a causal link between the vaccine and coagulation events, so the investigation will continue.

The World Health Organization, the UK Medicines Agency and the International Society on Thrombosis and Hemostasis have all stated that the benefits of administering the Oxford-AstraZeneca shot far outweigh the risks.

AstraZeneca previously said that its studies didn’t find a higher risk of blood clots as a result of its vaccine.

Most countries have since resumed the use of the shot, but many have suspended vaccinations for certain age groups.

A senior European Medicines Agency official said Tuesday that there was a clear “link” between the Oxford-AstraZeneca vaccine and very rare blood clots in the brain, although the direct cause was not yet known.

In an interview with the Italian newspaper Il Messaggero published on Tuesday, Marco Cavaleri, chairman of the EMA’s vaccine evaluation team, said: “In my opinion, we can now say that there is a link to the vaccine, but we are still me don’t know what is causing this reaction. “

The EMA then denied in a statement to Agence France-Presse that it had made a connection between the Oxford-AstraZeneca shot and rare blood clots.

UK vaccine study in children paused

The drug and health products regulator, which approved the Oxford-AstraZeneca vaccine for use in the UK, examined the data after a handful of reports – in both the UK and continental Europe – of serious but rare blood clots, some of which were fatal .

A UK study of the Oxford AstraZeneca vaccine in children has already been paused while the drug agency investigated a possible link between the shot and the bleeding disorders, particularly cases of blood clots in veins in the brain known as cerebral venous sinus thrombosis (CVST) as well Thrombocytopenia (low levels of platelets in the blood that help blood to clot).

The UK government noted that as of March 24th inclusive, there were 22 reports of CVST and 8 reports of other low platelet thrombosis events totaling 18.1 million doses of the AstraZeneca vaccine (one shot with two doses). given up to this date.

People are waiting in a vaccination center in Cologne on April 5, 2021.

Marius Becker | Image Alliance | Getty Images

“We need to know more about those affected and understand exactly how the diseases came about while many other questions remain open,” said Adam Finn, professor of pediatrics at Bristol University, UK, ahead of the announcement on Wednesday.

“There are some things that are very clear, however. The first is that these cases are indeed very rare. The second is that the vaccines available and used in the UK are very effective in preventing COVID,” said Finn.

“In short, if you are currently offered a dose of Oxford AstraZeneca vaccine, your chances of staying alive and staying healthy will go up if you take the vaccine and go down if you don’t.”

– CNBC’s Holly Ellyatt contributed to this report.

Categories
Business

Amazon Illegally Fired Activist Staff, Labor Board Finds

Amazon Illegally Fired Activist Workers, Labor Board Finds

SEATTLE – Amazon illegally battled two of its most prominent internal critics when it fired them last year, the National Labor Relations Board found.

Employees Emily Cunningham and Maren Costa had publicly urged the company to reduce its impact on climate change and address concerns about warehouse workers.

The agency told Ms. Cunningham and Ms. Costa that they would accuse Amazon of unfair labor practices if the company did not resolve the case. This emerges from correspondence Ms. Cunningham shared with the New York Times.

“It is a moral victory and it really shows that we are on the right side of history and the right side of the law,” said Ms. Cunningham.

The two women were among dozens of Amazon workers who told the Labor Department of the company’s retaliation last year, but in most of the other cases the workers had complained about the safety of pandemics.

“We support the right of every employee to criticize the working conditions of their employer, but that does not imply blanket immunity from our internal guidelines, which are all lawful,” said Jaci Anderson, a spokeswoman for Amazon. “We fired these employees because they did not speak publicly about working conditions, safety or sustainability, but because they repeatedly violated internal guidelines.”

Allegations of unfair labor practices at Amazon were common enough for the employment agency to convert them into a national investigation, the agency told NBC News. The agency usually conducts the investigation in its regional offices.

While Amazon’s starting wage of $ 15 an hour is twice the federal minimum, its labor practices in Washington and elsewhere are under scrutiny. The focus has increased over the past year as online orders soared during the pandemic and Amazon expanded its US workforce to nearly a million people. Amazon’s warehouse workers are considered key employees and have not been able to work from home.

This week, the National Labor Board is counting thousands of ballots determining whether nearly 6,000 workers will unionize at an Amazon warehouse outside of Birmingham, Alabama. This is the largest and most viable work threat in the company’s history. The union has stated that workers are under excessive production pressures and are closely monitored by the company to ensure quotas are respected.

The results could change the shape of the labor movement and one of America’s largest private employers.

Ms. Costa and Ms. Cunningham, who worked as designers at Amazon’s Seattle headquarters, began publicly criticizing the company in 2018. You were among a small group of employees who wanted the company to do more to manage the climate impact. The group, Amazon Employees for Climate Justice, has more than 8,700 colleagues to support their efforts.

Over time, Ms. Cunningham and Ms. Costa have expanded their protests. After Amazon told them that they had violated its external communications guidelines by speaking publicly about the company, their group organized 400 people to speak up and deliberately violated the guidelines to make a point .

At the start of the pandemic, they also raised concerns about the safety of Amazon’s warehouses. Amazon fired Ms. Costa and Ms. Cunningham last April, not long after their group announced an internal event where warehouse workers would speak to technical staff about their working conditions.

After the women were released, several Democratic senators, including Elizabeth Warren of Massachusetts and Kamala Harris of California, wrote to Amazon of concerns about possible retaliation. And Tim Bray, an internet pioneer and former vice president of the Amazon Cloud Computing Group, stepped down in protest.

Mr Bray said he was delighted to hear the employment office’s findings and hoped Amazon had settled the case. “The policy so far has been ‘don’t admit anything, don’t admit anything’,” he said. “This is your chance to think it over a little.”

Ms. Cunningham said that despite the company’s rejection, she and Ms. Costa felt that they and Ms. Costa were primary targets for Amazon as they were the most visible members of Amazon Employees for Climate Justice.

The Labor Authority also upheld a complaint involving Jonathan Bailey, co-founder of Amazonians United, a workforce advocacy group. The agency filed a complaint against Amazon based on Mr Bailey’s allegations that the company was breaking the law when it interrogated him after a strike last year at the Queens warehouse where he works.

“They realized that Amazon violated our rights,” said Bailey. “I think the message that employees should hear and understand is, yes, we all experience it. But many of us struggle too. “

Amazon has resolved Mr Bailey’s case without admitting any wrongdoing and has agreed to post notices informing employees of their rights in the break room. Ms. Anderson, Amazon’s spokeswoman, said the company contradicts allegations in Mr. Bailey’s case. “We pride ourselves on providing an inclusive environment in which employees can perform excellently without fear of retaliation, intimidation or harassment,” she said.

Kate Conger contributed to the coverage.

Categories
Health

CDC examine finds about 78% of individuals hospitalized have been chubby or overweight

CDC study finds about 78% of people hospitalized were overweight or obese

A woman walks down the street on Michigan Avenue in Chicago, Illinois.

Jeff Haynes | AFP | Getty Images

An overwhelming majority of people who were hospitalized, needed a ventilator, or died of Covid-19 were overweight or obese, the CDC said in a new study on Monday.

Of 148,494 adults diagnosed with Covid-19 during an emergency room or inpatient visit at 238 U.S. hospitals from March to December, 71,491 were hospitalized. According to the CDC report, 27.8% of those admitted were overweight and 50.2% were obese. Overweight has a body mass index of 25 or more, while obesity has a BMI of 30 or more.

The agency found that the risk of hospitalizations, ICU admissions, and deaths were lowest among those with BMIs under the age of 25. However, the risk of serious illness “rose sharply” as BMIs increased, particularly in those 65 and over.

According to the latest statistics from the agency, just over 42% of the US population was considered obese in 2018.

It doesn’t take many extra pounds to be considered overweight or obese. A 5-foot-10-inch 175-pound man and a 5-foot-4-inch 146-pound woman with a BMI of just over 25 would be considered obese, according to the CDC’s BMI calculator. A man and woman of the same height would be considered obese at 210 pounds and 175 pounds, respectively.

“When clinicians develop care plans for COVID-19 patients, they should consider the risk of serious outcomes in patients with higher BMI, especially those with severe obesity,” the agency wrote.

The CDC added that the results highlight the clinical and health implications of higher BMIs, including promoting Covid prevention strategies such as continued prioritization, masking and vaccine guidelines to ensure population access to diet and physical activity.

Obesity is a common and costly chronic disease in the United States. Non-Hispanic black adults have the highest prevalence of self-reported obesity in the United States, followed by Hispanic adults and non-Hispanic whites, according to the CDC.

The CDC previously found that obesity increases the risk of serious illnesses, including hospitalization. Obesity is linked to impaired immune function and decreased lung capacity, which can make ventilation difficult, the agency said.

The study had limitations, the CDC said. Risk estimates for severe Covid-19 were only measured in adults who were treated in a hospital. Therefore, these estimates could differ from the risk in all adults with Covid, the CDC said. In addition, only patients with information on height and weight were included in the report.

The CDC received data from PHD-SR, a large database in hospitals.